USP revises heparin labelling guide
The US Pharmacopeial Convention (USP) has changed its labelling rules for heparin in a mid to reduce the number of medication errors.
The US Pharmacopeial Convention (USP) has changed its labelling rules for heparin in a mid to reduce the number of medication errors.
GSK has withdrawn another lot of its Infanrix Hexa vaccine over concerns about potential microbial contamination.
GE has made its second move in the CRO space in a year by investing in Biocon’s IPO bound contract research unit.
The organisational changes BASF announced yesterday will not impact drug ingredients or excipients but intermediates will be rejigged.
Icon has followed up an impressive set of Q3 results and plans to delist in Ireland with the announcement of a new FSP focused strategy.